{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T12:30:05Z","timestamp":1787056205125,"version":"build-2736575974"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background and Objectives:<\/jats:title>\n                    <jats:p>Inflammatory neuropathies are a heterogeneous group of disorders of the peripheral nerves. Pathogenic antibodies targeting various antigens at the node\u2013paranode junctions, leading to its disorganization, are increasingly recognized as accounting for an important subset of inflammatory neuropathies. Among these, antibodies against neurofascin (NF)155 and NF186 are the most widely recognized. The current study aimed to determine the prevalence of NF155 and NF186 antibodies in an Indian cohort of patients with inflammatory neuropathies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Seventy-six patients with inflammatory neuropathies, including 44 with Guillain-Barr\u00e9 syndrome (GBS) and 32 with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), and 32 healthy controls were recruited. NF155 and NF186 antibodies were tested in sera from all study participants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>In this study, 8\/76 (10.53%) patients with inflammatory neuropathies tested positive for NF186 antibodies, including 5 (11.36%) with GBS and 3 (9.37%) with CIDP. Given the small sample size, definitive differences between the NF186 antibody-positive and antibody-negative groups could not be established. None of the patients with GBS and NF186 antibody positivity required mechanical ventilation. None of the patients with CIDP and NF186 antibody positivity had an acute GBS-like onset. One patient in the NF186 antibody-positive CIDP group had the phenotype of combined central and peripheral demyelination. None of the study participants tested positive for NF155 antibodies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>A higher proportion of GBS patients showed NF186 reactivity in the present study than in previous reports. The spectrum of other pathogenic antibodies remains to be tested, as the majority of patients with inflammatory neuropathies tested negative for the two NF antibodies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/aian.aian_1212_25","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T07:00:09Z","timestamp":1785913209000},"page":"562-569","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Neurofascin Antibodies in a Large Cohort of Inflammatory Neuropathies from India"],"prefix":"10.4103","volume":"29","author":[{"given":"Madhu","family":"Nagappa","sequence":"first","affiliation":[{"name":"Department of Neurology, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Pradeepkumar","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandipan","family":"Mondal","sequence":"additional","affiliation":[{"name":"Department of Human Genetics, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Kammar","sequence":"additional","affiliation":[{"name":"Department of Human Genetics, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pokala","family":"Akhil","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinath","family":"Rajeevan","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshaya","family":"Janardhanan","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monojit","family":"Debnath","sequence":"additional","affiliation":[{"name":"Department of Human Genetics, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"key":"R1-20260818","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/B978-0-323-98818-6.00026-1","article-title":"Acute\/chronic inflammatory polyradiculoneuropathy","volume":"195","author":"Miranda","year":"2023","journal-title":"Handb Clin Neurol"},{"key":"R2-20260818","doi-asserted-by":"crossref","first-page":"14411","DOI":"10.1038\/s41598-017-14853-4","article-title":"Antibodies against peripheral nerve antigens in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"7","author":"Querol","year":"2017","journal-title":"Sci Rep"},{"key":"R3-20260818","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3389\/fimmu.2018.01029","article-title":"Autoantibodies against the node of ranvier in seropositive chronic inflammatory demyelinating polyneuropathy: Diagnostic, pathogenic, and therapeutic relevance","volume":"9","author":"Vural","year":"2018","journal-title":"Front Immunol"},{"key":"R4-20260818","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0960-9822(01)00680-7","article-title":"Neurofascin is a glial receptor for the paranodin\/Caspr-contactin axonal complex at the axoglial junction","volume":"12","author":"Charles","year":"2002","journal-title":"Curr Biol"},{"key":"R5-20260818","doi-asserted-by":"crossref","first-page":"7907","DOI":"10.1074\/jbc.M113.528489","article-title":"Specific contactin N-glycans are implicated in neurofascin binding and autoimmune targeting in peripheral neuropathies","volume":"289","author":"Labasque","year":"2014","journal-title":"J Biol Chem"},{"key":"R6-20260818","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1002\/jnr.22015","article-title":"Spatiotemporal ablation of myelinating glia-specific neurofascin (Nfasc NF155) in mice reveals gradual loss of paranodal axoglial junctions and concomitant disorganization of axonal domains","volume":"87","author":"Pillai","year":"2009","journal-title":"J Neurosci Res"},{"key":"R7-20260818","doi-asserted-by":"crossref","first-page":"a020495","DOI":"10.1101\/cshperspect.a020495","article-title":"The Nodes of Ranvier: Molecular Assembly and Maintenance","volume":"8","author":"Rasband","year":"2015","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"R8-20260818","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.neuron.2010.12.016","article-title":"Nodes of Ranvier act as barriers to restrict invasion of flanking paranodal domains in myelinated axons","volume":"69","author":"Thaxton","year":"2011","journal-title":"Neuron"},{"key":"R9-20260818","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.nmd.2016.10.008","article-title":"Paranodal lesions in chronic inflammatory demyelinating polyneuropathy associated with anti-Neurofascin 155 antibodies","volume":"27","author":"Vallat","year":"2017","journal-title":"Neuromuscul Disord"},{"key":"R10-20260818","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/brain\/awn281","article-title":"Disruption of neurofascin and gliomedin at nodes of Ranvier precedes demyelination in experimental allergic neuritis","volume":"132","author":"Lonigro","year":"2009","journal-title":"Brain"},{"key":"R11-20260818","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1212\/WNL.0000000000002418","article-title":"Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy","volume":"86","author":"Devaux","year":"2016","journal-title":"Neurology"},{"key":"R12-20260818","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1212\/WNL.0b013e3182a1aa9c","article-title":"Anti-neurofascin antibody in patients with combined central and peripheral demyelination","volume":"81","author":"Kawamura","year":"2013","journal-title":"Neurology"},{"key":"R13-20260818","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain-Barr\u00e9 syndrome","volume":"27","author":"Asbury","year":"1990","journal-title":"Ann Neurol"},{"key":"R14-20260818","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1111\/ene.14959","article-title":"European Academy of Neurology\/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision","volume":"28","author":"Van den Bergh","year":"2021","journal-title":"Eur J Neurol"},{"key":"R15-20260818","doi-asserted-by":"crossref","first-page":"779385","DOI":"10.3389\/fnmol.2021.779385","article-title":"Impact of neurofascin on chronic inflammatory demyelinating polyneuropathy via changing the node of Ranvier function: A review","volume":"14","author":"Gao","year":"2021","journal-title":"Front Mol Neurosci"},{"key":"R16-20260818","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1093\/brain\/awq372","article-title":"Neurofascin as target of autoantibodies in Guillain-Barre syndrome","volume":"134","author":"Pr\u00fcss","year":"2011","journal-title":"Brain"},{"key":"R17-20260818","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1529-8027.2012.00372.x","article-title":"Nodal proteins are target antigens in Guillain-Barr\u00e9 syndrome","volume":"17","author":"Devaux","year":"2012","journal-title":"J Peripher Nerv Syst"},{"key":"R18-20260818","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1212\/WNL.0b013e31827689ad","article-title":"Neurofascin as a target for autoantibodies in peripheral neuropathies","volume":"79","author":"Ng","year":"2012","journal-title":"Neurology"},{"key":"R19-20260818","doi-asserted-by":"crossref","first-page":"e603","DOI":"10.1212\/NXI.0000000000000603","article-title":"Anti-pan-neurofascin IgG3 as a marker of fulminant autoimmune neuropathy","volume":"6","author":"Stengel","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"R20-20260818","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12974-021-02301-0","article-title":"Autoantibody screening in Guillain-Barr\u00e9 syndrome","volume":"18","author":"Lleix\u00e0","year":"2021","journal-title":"J Neuroinflammation"},{"key":"R21-20260818","doi-asserted-by":"crossref","first-page":"107521","DOI":"10.1016\/j.clineuro.2022.107521","article-title":"Characterization of the patients with antibodies against nodal-paranodal junction proteins in chronic inflammatory demyelinating polyneuropathy","volume":"223","author":"Dong","year":"2022","journal-title":"Clin Neurol Neurosurg"},{"key":"R22-20260818","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1212\/WNL.0000000000004773","article-title":"Neurofascin antibodies in autoimmune, genetic, and idiopathic neuropathies","volume":"90","author":"Burnor","year":"2018","journal-title":"Neurology"},{"key":"R23-20260818","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1093\/brain\/awx124","article-title":"Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy","volume":"140","author":"Delmont","year":"2017","journal-title":"Brain"},{"key":"R24-20260818","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jneuroim.2016.10.013","article-title":"IgG4 anti-neurofascin155 antibodies in chronic inflammatory demyelinating polyradiculoneuropathy: Clinical significance and diagnostic utility of a conventional assay","volume":"301","author":"Kadoya","year":"2016","journal-title":"J Neuroimmunol"},{"key":"R25-20260818","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1212\/WNL.0000000000000205","article-title":"Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg","volume":"82","author":"Querol","year":"2014","journal-title":"Neurology"},{"key":"R26-20260818","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/acn3.51550","article-title":"Clinical and diagnostic features of anti-neurofascin-155 antibody-positive neuropathy in Han Chinese","volume":"9","author":"Wang","year":"2022","journal-title":"Ann Clin Transl Neurol"},{"key":"R27-20260818","doi-asserted-by":"crossref","first-page":"577074","DOI":"10.1016\/j.jneuroim.2019.577074","article-title":"Chronic inflammatory demyelinating polyneuropathy with anti-NF155 IgG4 in China","volume":"337","author":"Zhang","year":"2019","journal-title":"J Neuroimmunol"},{"key":"R28-20260818","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1212\/NXI.0000000000000238","article-title":"Neurofascin-155 as a putative antigen in combined central and peripheral demyelination","volume":"3","author":"Cortese","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"R29-20260818","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/mus.70121","article-title":"Spectrum of anti-neurofascin neuropathies: A retrospective Indian cohort","volume":"73","author":"Khadilkar","year":"2026","journal-title":"Muscle Nerve"},{"key":"R30-20260818","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1093\/brain\/awac418","article-title":"Anti-pan-neurofascin antibodies induce subclass-related complement activation and nodo-paranodal damage","volume":"146","author":"Appeltshauser","year":"2023","journal-title":"Brain"}],"container-title":["Annals of Indian Academy of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/aian.aian_1212_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T12:01:30Z","timestamp":1787054490000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aian.aian_1212_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/aian.aian_1212_25","relation":{},"ISSN":["0972-2327","1998-3549"],"issn-type":[{"value":"0972-2327","type":"print"},{"value":"1998-3549","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"2025-11-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}